ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
6,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
7,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
9,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
10,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
13,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
13,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
13,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
14,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
14,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
15,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
15,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
16,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
17,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
17,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
17,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
17,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
17,7,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
17,8,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
18,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
18,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
19,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
20,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
20,2,Brain natriuretic peptide abnormal,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
20,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
20,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
20,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
20,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
20,7,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
21,1,Blood pressure inadequately controlled,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
22,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
23,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
23,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
24,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
24,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
25,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
25,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
25,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
26,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
27,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
